Columbia University in the City of New York · NeuroscienceIntracerebral Hemorrhage Research Lab
David Roh · New York, New York
Research Focus
Dr. David Roh's lab at Columbia University focuses on improving treatments for patients suffering from intracerebral hemorrhage (ICH), a severe type of stroke. They explore how to better diagnose coagulation issues that lead to ongoing bleeding and worse neurological outcomes in ICH patients. By using advanced blood tests and specialized assays, the lab aims to develop more precise treatments that can prevent complications and improve patient recovery.
intracerebral hemorrhagecoagulationstrokeblood assaysneuroimaging
Research Aims
5AIM 01Identify specific coagulation issues in ICH patients using advanced testing methods.
AIM 02Develop tailored treatment strategies to prevent hematoma expansion in ICH cases.
AIM 03Explore the relationship between coagulation drivers and neurological outcomes after ICH.
AIM 04Utilize multimodal assessments to gather comprehensive data on coagulation and bleeding.
AIM 05Improve current diagnostic approaches to better identify patients at risk for ICH complications.
Skills the Lab Values
whole blood viscoelastic assaysclinical coagulation testingproteomicsdata analysisneuroimaging techniques
Output against the department
Publications220top 34% of dept.225th of 671
this lab
most publishedleast published
Citations3.7kbottom 28% of dept.485th of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.